Reply to "Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety
J Clin Psychiatry 2005;66(11):1495 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
We appreciate the response of Ms. McClendon to our article
on paroxetine and cognitive-behavioral therapy (CBT) in
the treatment of comorbid postpartum depression and anxiety.
We agree that our findings are from women with severe comorbid
depression and anxiety, as indicated by their Hamilton Rating
Scale for Depression and Hamilton Rating Scale for Anxiety
scores at baseline, and are therefore representative of only this
select population. Due to the relative lack of research on the
clinical effectiveness of combined pharmacologic and psychological
interventions for postpartum depression and anxiety, the
primary aim of the study was to provide readers with preliminary
information on this subject taken from a select sample
treated at a tertiary hospital outpatient clinic.